413
Participants
Start Date
November 5, 2019
Primary Completion Date
December 15, 2027
Study Completion Date
December 15, 2027
revumenib
revumenib orally
cobicistat
Phase 1 Arm C participants will receive 150 mg cobicistat daily.
RECRUITING
Royal North Shore Hospital, Saint Leonards
RECRUITING
Peter MacCallum Cancer Centre (PMCC), Melbourne
RECRUITING
Alfred Hospital, Melbourne
RECRUITING
Royal Melbourne Hospital (RMH), Parkville
RECRUITING
Sir Charles Gairdner Hospital, Nedlands
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Montefiore Medical Center, New York
RECRUITING
Universitaetsmedizin Greifswald, Greifswald
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
IRCCS-Istituto Europeo di Oncologia, Milan
RECRUITING
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
RECRUITING
Duke University Medical Center, Durham
RECRUITING
Emory Winship Cancer Institute, Atlanta
COMPLETED
Children's Healthcare of Atlanta, Atlanta
COMPLETED
Moffitt Cancer Center, Tampa
RECRUITING
Centre Hospitalier Universitaire (CHU) de Bordeaux, Pessac
RECRUITING
Florida Cancer Specialists and Research Institute, Sarasota
RECRUITING
S Bortolo Hospital AULSS 8 Berica, Vicenza
RECRUITING
IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna
RECRUITING
Hospital Universitario Virgen del Rocio, Seville
RECRUITING
Ohio State University, Columbus
WITHDRAWN
Universitaetsklinikum Essen (AoR), Essen
RECRUITING
University of Cincinnati, Cincinnati
RECRUITING
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
RECRUITING
Istituto Romagnolo Per Lo Studio dei tumori Dino Amadori, Meldola
RECRUITING
University of Iowa hospital, Iowa City
RECRUITING
Sheba Medical Center, Ramat Gan
RECRUITING
Universitaetsmedizin Der Johannes, Gutenberg
RECRUITING
The University of Chicago Medical Center, Chicago
RECRUITING
Washington University in St. Louis School of Medicine, St Louis
RECRUITING
Centre Hospitalier Lyon Sud, Pierre-Bénite
RECRUITING
Hospital Saint-Louis - APHP, Paris
RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
RECRUITING
University of Colorado, Aurora
COMPLETED
Huntsman Cancer Institute at the University of Utah, Salt Lake City
RECRUITING
University Hospital Of Ulm, Universitatsklinikum Ulm, Ulm
RECRUITING
University Of California Care Medical Group - Norris Comprehensive Cancer Center And Hospital, Los Angeles
RECRUITING
Klinikum Nuernberg Nord, Nuremberg
RECRUITING
City of Hope Comprehensive Cancer Center, Duarte
RECRUITING
Stanford Cancer Institute, Palo Alto
RECRUITING
Institut Gustave Roussy-Gustave Roussy Cancer Center -DITEP, Villejuif
RECRUITING
Oregon Health & Science University, Portland
RECRUITING
Galilee Medical Center, Nahariya
RECRUITING
Rambam Health Care Campus (RHCC, Haifa
RECRUITING
Rabin Medical Center, Petah Tikva
RECRUITING
Shaare Zedek Medical Center, Jerusalem
RECRUITING
Hadassah Medical Center- Ein Kerem, Jerusalem
RECRUITING
Dana Farber Cancer Institute, Boston
COMPLETED
Hackensack University Medical Center, Hackensack
RECRUITING
University Health Network, Toronto
RECRUITING
The Hospital for Sick Children, Toronto
RECRUITING
University of Leipzig, Leipzig
RECRUITING
Universita Cattolica Fondazione Policlinico Agostino Gemelli, Roma
RECRUITING
Vilnius University Hospital Santaros Klinikos, Vilnius
RECRUITING
Princess Maxima Center for Pediatric Oncology, Utrecht
RECRUITING
Hospital Centro Comprensivo de Cancer UPR, San Juan
RECRUITING
Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Lead Sponsor
Syndax Pharmaceuticals
INDUSTRY